| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/11/2013 | CN102766634B Single-stranded deoxyribonucleic acid (ssDNA) aptamer targeting human highly metastatic hepatoma carcinoma cell and application thereof |
| 09/11/2013 | CN102764246B Trospium chloride controlled release capsule and preparation method thereof |
| 09/11/2013 | CN102716469B Dry powder inhalant of interferon alpha |
| 09/11/2013 | CN102697703B Piroxicam gel preparation and preparation method thereof |
| 09/11/2013 | CN102671213B Scutellarin prodrug and preparation method thereof |
| 09/11/2013 | CN102670537B Trimetazidine dihydrochloride sustained release tablet and preparation method thereof |
| 09/11/2013 | CN102648899B Child cefalexin composition |
| 09/11/2013 | CN102604138B Method for preparing chitosan substrate film by self-deposition of micron gel |
| 09/11/2013 | CN102600143B Vinpocetine medicament composition and preparation method thereof |
| 09/11/2013 | CN102423298B Preparation method of core-shell structure collagen polypeptide chelated calcium nanoparticle |
| 09/11/2013 | CN102370617B Ophthalmic huperzine A microemulsion and preparation method thereof |
| 09/11/2013 | CN102316901B Transdermal preparation |
| 09/11/2013 | CN102283816B Silodosin sustained-release tablet and preparation method thereof |
| 09/11/2013 | CN102247316B Hydrophobic coating for controlling drug release and preparation method thereof |
| 09/11/2013 | CN102159248B Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds |
| 09/11/2013 | CN102138905B RhBMP-2-loaded chitosan microspheres, preparation method thereof and application thereof |
| 09/11/2013 | CN102038963B Method for preparing a stabilised menthol emulsion |
| 09/11/2013 | CN102000341B Polyethylene oxide and matrix type surfactant in suppository composition |
| 09/11/2013 | CN101991538B TPGS-containing liposome composition and application thereof |
| 09/11/2013 | CN101890169B Moxifloxacin oral preparation and preparation method thereof |
| 09/11/2013 | CN101836978B Solid preparation containing single crystal form |
| 09/11/2013 | CN101822665B Ascaridol gastric retention preparation and preparation method thereof |
| 09/11/2013 | CN101820877B Agent for fungal dermatitis |
| 09/11/2013 | CN101810583B HIV (Human Immunodeficiency Virus) fusion inhibitor slow-release microsphere |
| 09/11/2013 | CN101735991B Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| 09/11/2013 | CN101583341B Eyelid scrub composition |
| 09/11/2013 | CN101559241B Hyaluronic acid-hydroxyapatite nano composite sphere and preparation method |
| 09/10/2013 | US8530625 Silk-based drug delivery system |
| 09/10/2013 | US8530527 Food ingredients from Stevia rebaudiana |
| 09/10/2013 | US8530526 Biobeneficial coating compositions and methods of making and using thereof |
| 09/10/2013 | US8530225 Therapeutic agents comprising pro-apoptotic proteins |
| 09/10/2013 | US8529979 Stable emulsions of oils in aqueous solutions and methods for producing same |
| 09/10/2013 | US8529969 Treatment of the guar split with an alkaline solution and hydrogen peroxide, partial neutralization with acid, removal of peripheral cell layers of the guar split, treating split with aqueous alcohol, grinding; clarity; use as thickener |
| 09/10/2013 | US8529928 Biomimetic polymers and uses thereof |
| 09/10/2013 | US8529922 Polymer formulations for delivery of bioactive materials |
| 09/10/2013 | US8529871 in a patient receiving high dose radioactive iodine for treatment of cancer; administering to the eyes of said patient an effective amount of perchlorate anion |
| 09/10/2013 | CA2731769C Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders |
| 09/10/2013 | CA2693296C Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 09/10/2013 | CA2633125C Adhesive pharmaceutical preparation containing bisoprolol |
| 09/10/2013 | CA2610987C Stabilizer for protein preparation comprising meglumine and use thereof |
| 09/10/2013 | CA2610414C Skin patch |
| 09/10/2013 | CA2598823C Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| 09/10/2013 | CA2597688C Agglomerated starch compositions |
| 09/10/2013 | CA2597407C Process for preparing stable drug conjugates |
| 09/10/2013 | CA2595894C Percutaneously absorbable preparation, percutaneously absorbable preparation holding sheet, and percutaneously absorbable preparation holding equipment |
| 09/10/2013 | CA2544483C Soluble tcr fusion molecules and methods of use |
| 09/10/2013 | CA2529027C D-amino acid peptides |
| 09/10/2013 | CA2431964C Conjugates of erythropoietin (pep) with polyethylene glycol (peg) |
| 09/10/2013 | CA2427340C Cyp1b1 nucleic acids and methods of use |
| 09/10/2013 | CA2413237C Alteration of cell membrane for new functions |
| 09/10/2013 | CA2331789C Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 09/10/2013 | CA2272245C Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies |
| 09/06/2013 | WO2013130814A1 Novel prodrug containing molecule compostions and their uses |
| 09/06/2013 | WO2013130766A1 Spray dried formulations |
| 09/06/2013 | WO2013130669A1 Pharmaceutical composition and administration thereof |
| 09/06/2013 | WO2013130666A1 Alkylated cyclodextrin compositions and processes for preparing and using the same |
| 09/06/2013 | WO2013130535A1 Topical delivery of hormonal and non hormonal nano formulations, methods of making and using the same |
| 09/06/2013 | WO2013129944A1 Controlled release compositions and their methods of use |
| 09/06/2013 | WO2013128194A1 Immunotherapeutic molecules and uses |
| 09/06/2013 | WO2013127912A1 Superparamagnetic nanoparticles with peg substituted alpha-hydroxy phosponate shells |
| 09/06/2013 | WO2013127885A1 A conjugate of methotrexate and hydroxyethyl starch for use in the treatment cancer |
| 09/06/2013 | WO2013127829A1 Protease-resistant compounds useful as shuttles through the blood-brain barrier and shuttle-cargo constructs |
| 09/06/2013 | WO2013127728A1 Hormone containing emulsion |
| 09/06/2013 | WO2013127727A1 Hormone containing emulsion comprising krill phospholipids |
| 09/06/2013 | WO2013127374A1 Derivates based on hyaluronic acid, capable of forming hydrogels, method of preparation thereof, hydrogels based on said derivatives, method of preparation thereof and use |
| 09/06/2013 | WO2013127004A1 Polymeric nanoparticles useful in theranostics |
| 09/06/2013 | WO2013126990A1 Method for the preparation of triglycerides of medium-chain length fatty acids |
| 09/06/2013 | WO2013100818A3 A biocomposite for regeneration of injured tissue and organs, a kit for making the biocomposite, a method of making the biocomposite and a method of treating inquiries. |
| 09/06/2013 | WO2013078564A3 Targeted lysosomal enzyme compounds |
| 09/06/2013 | WO2013078562A3 Targeted iduronate-2-sulfatase compounds |
| 09/06/2013 | WO2013033450A3 Remote assembly of targeted nanoparticles using h-phosphonate-ene/-yne hydrophosphonylation reactions |
| 09/05/2013 | US20130231399 Azeotrope-like compositions comprising 1-chloro-3,3,3-trifluoropropene |
| 09/05/2013 | US20130231390 Pharmaceutical composition of ibuprofen for injection |
| 09/05/2013 | US20130231382 Lipopeptides for delivery of nucleic acids |
| 09/05/2013 | US20130231310 Mesalamine suppository |
| 09/05/2013 | US20130231281 Rapid acting insulin formulation comprising an oligosaccharide |
| 09/05/2013 | US20130230899 Therapeutic agent for arteriosclerosis or arteriosclerotic disease, and diagnostic agent for arteriosclerosis or arteriosclerotic disease |
| 09/05/2013 | US20130230598 Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid |
| 09/05/2013 | US20130230593 Orally Dosed Pharmaceutical Compositions Comprising a Delivery Agent in Micronized Form |
| 09/05/2013 | US20130230588 Controlled release compositions |
| 09/05/2013 | US20130230568 Stable Formulations for Lyophilizing Therapeutic Particles |
| 09/05/2013 | US20130230562 Fusion protein comprising small heat shock protein, cage protein formed thereby, and novel use thereof |
| 09/05/2013 | US20130230534 Interferon Receptor 1 Antibodies And Their Uses |
| 09/05/2013 | US20130230519 Anti-serum albumin binding variants |
| 09/05/2013 | US20130230515 Myostatin binding agents |
| 09/05/2013 | US20130230496 Graphene hydrogel and method for using the same |
| 09/05/2013 | US20130230495 Amphiphilic chitosan nanogel as an injectable delivery system for stem cell therapy |
| 09/05/2013 | US20130230493 Photocrosslinked biodegradable hydrogel |
| 09/05/2013 | US20130230490 PEG-Interferon Lambda 1 Conjugates |
| 09/05/2013 | US20130230472 Bonding tissues and cross-linking proteins with naphthalimide compounds |
| 09/04/2013 | EP2634194A1 Anti-cdh3 antibody having high internalization capacity |
| 09/04/2013 | EP2634177A1 Tau imaging probe |
| 09/04/2013 | EP2633866A2 Combination therapy |
| 09/04/2013 | EP2633852A1 Jojoba oil-containing ophthalmic spray composition |
| 09/04/2013 | EP2632949A1 Clostridium difficile-specific antibodies and uses thereof |
| 09/04/2013 | EP2632948A1 Spider silk fusion protein structures for binding to an organic target |
| 09/04/2013 | EP2632505A2 Material for medical use comprising nanoparticles with superparamagnetic properties and its utilization in surgery |
| 09/04/2013 | EP2632493A2 Drug delivery compositions |
| 09/04/2013 | EP2632490A2 Novel egfr-binding molecules and immunoconjugates thereof |
| 09/04/2013 | EP2632473A1 A detoxifier herbal formulation |